References
- E.O. Bayman, K. Chaloner, and M.K. Cowles, Detecting qualitative interaction: A Bayesian approach, Stat. Med. 29 (2010), pp. 455–463.
- J.O. Berger, X. Wang, and L. Shen, A Bayesian approach to subgroup identification, J. Biopharm. Stat. 24 (2014), pp. 110–129. doi: 10.1080/10543406.2013.856026
- J.G. Booth and J.P. Hobert, Standard errors of prediction in generalized linear mixed models, J. Amer. Statist. Assoc. 93 (1998), pp. 262–272. doi: 10.1080/01621459.1998.10474107
- B.P. Carlin and T.A. Louis, Empirical Bayes: Past, present and future, J. Amer. Statist. Assoc. 95 (2000), pp. 1286–1289. doi: 10.1080/01621459.2000.10474331
- B.P. Carlin and T.A. Louis, Bayesian Methods for Data Analysis, 3rd ed., Chapman and Hall/CRC, Boca Raton, 2009.
- G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller, Efficacy of bcg vaccine in the prevention of tuberculosis, J. Am. Med. Assoc. 271 (1994), pp. 698–702. doi: 10.1001/jama.1994.03510330076038
- S. Dalal and W. Hall, Approximating priors by mixtures of natural conjugate priors, J. R. Stat. Soc. Ser. B 45 (1983), pp. 278–286.
- C.E. Davis and D.P. Leffingwell, Empirical Bayes estimates of subgroup effects in clinical trials, Control. Clin. Trials 11 (1990), pp. 37–42. doi: 10.1016/0197-2456(90)90030-6
- A.P. Dempster, N.M. Laird, and D.B. Rubin, Maximum likelihood from incomplete data via the EM algorithm (with discussion), J. R. Stat. Soc. B 39 (1977), pp. 1–38.
- R. DerSimonian and N. Laird, Meta-analysis in clinical trials, Control. Clin. Trials 7 (1986), pp. 177–188. doi: 10.1016/0197-2456(86)90046-2
- W. DuMouchel, Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system, Am. Stat. 53 (1999), pp. 177–190.
- B. Efron, Size, power and false discovery rates, Ann. Statist. 35 (2007), pp. 1351–1377. doi: 10.1214/009053606000001460
- B. Efron, Tweedie's formula and selection bias, J. Amer. Statist. Assoc. 106 (2011), pp. 1602–1614. doi: 10.1198/jasa.2011.tm11181
- B. Efron and C. Morris, Stein's estimation rule and its competitors – an empirical Bayes approach, J. Amer. Statist. Assoc. 68 (1973), pp. 117–130.
- B. Efron and C. Morris, Data analysis using Stein's estimator and its generalizations, J. Amer. Statist. Assoc. 70 (1975), pp. 311–319. doi: 10.1080/01621459.1975.10479864
- S. Greenland, Principles of multilevel modelling, Int. J. Epidemiol. 29 (2000), pp. 158–167. doi: 10.1093/ije/29.1.158
- J.M. Grouin, M. Coste, and J. Lewis, Subgroup analyses in randomized clinical trials: Statistical and regulatory issues, J. Biopharm. Stat. 15 (2005), pp. 869–882. doi: 10.1081/BIP-200067988
- W. James and C. Stein, Estimation with quadratic loss, Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, 1961, pp. 361–379.
- H.E. Jones, D.I. Ohlssen, B. Neuenschwander, A. Racine, and M. Branson, Bayesian models for subgroup analysis in clinical trials, Clin. Trials 8 (2011), pp. 129–143. doi: 10.1177/1740774510396933
- R.E. Kass and D. Steffey, Approximate Bayesian inference in conditionally independent hierarchical models (parametric empirical Bayes models), J. Amer. Statist. Assoc. 84 (1989), pp. 717–726. doi: 10.1080/01621459.1989.10478825
- C.N. Morris, Parametric empirical Bayes inference: Theory and applications, J. Amer. Statist. Assoc. 78 (1983), pp. 47–55. doi: 10.1080/01621459.1983.10477920
- B. Neuenschwander, S. Wandel, S. Roychoudhury, and S. Bailey, Robust exchangeability designs for early phase clinical trials with multiple strata, Pharm. Stat. 15 (2015), pp. 123–134. doi: 10.1002/pst.1730
- J.S. Remington, B. Efron, E. Cavanaugh, H. Simon, and A. Trejos, Studies on toxoplasmosis in El Savador prevalence and incidence of toxoplasmosis as measured by the Sabin-Feldman dye test, Trans. R. Soc. Trop. Med. Hyg. 64 (1970), pp. 252–267. doi: 10.1016/0035-9203(70)90132-X
- H. Robbins, An empirical Bayes approach to statistics, Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability, 1956, pp. 157–163.
- G.K. Rosenkranz, An approach to integrated safety analyses of clinical studies, Drug. Inf. J. 44 (2010), pp. 649–657. doi: 10.1177/009286151004400601
- G.K. Rosenkranz, Bootstrap corrections of treatment effect estimates following selection, Comput. Statist. Data Anal. 69 (2014), pp. 220–227. doi: 10.1016/j.csda.2013.08.010
- H. Schmidli, S. Gsteiger, S. Roychoudhury, A. O'Hagan, D. Spiegelhalter, and B. Neuenschwander, Robust meta-analytic-predictive priors in clinical trials with historical control information, Biometrics 70 (2014), pp. 1023–1032. doi: 10.1111/biom.12242
- D.A. Schoenfeld, Sample-size formula for the proportional-hazards regression model, Biometrics 39 (1983), pp. 499–503. doi: 10.2307/2531021
- M.C. Simmonds and J.P.T. Higgins, A general framework for the use of logistic regression models in meta-analysis, Stat. Methods Med. Res. 25 (2016), pp. 2858–2877. doi: 10.1177/0962280214534409
- D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, and W.R. Sellers, Gene expression correlates of clinical prostate cancer behavior, Cancer Cell 1 (2002), pp. 203–209. doi: 10.1016/S1535-6108(02)00030-2
- C. Stein, Inadmissibility of the usual estimator for the mean of a multivariate normal distribution, Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability, 1956, pp. 197–206.
- M.C.K. Tweedie, Functions of a statistical variate with given means, with special reference to Laplacian distributions, Proc. Camb. Philos. Soc. 13 (1947), pp. 41–49. doi: 10.1017/S0305004100023185
- H.C. van Houwelingen, The role of empirical Bayes methodology as a leading principle in modern medical statistics, Biom. J. 56 (2014), pp. 919–932. doi: 10.1002/bimj.201400073
- R. Varadhan and S. -J. Wang, Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else, Biom. J. 58 (2016), pp. 133–153. doi: 10.1002/bimj.201400102
- J.D. Wallach, P.G. Sullivan, J.F. Trepanowski, K.L. Sainani, E.W. Steyerberg, and J.P.A. Ioannidis, Evaluation of evidence os statistical support and corroboration of subgroup claims in randomized clinical trials, JAMA. Intern. Med. 177 (2017), pp. 554–560.